🇺🇸 FDA
Pipeline program

Rituximab

RITULUP

Phase 3 mab terminated

Quick answer

Rituximab for Lupus Nephritis is a Phase 3 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Lupus Nephritis
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials